Nicolás Kirchuk

Biomakers Molecular Pathology & Research is a company based in Buenos Aires, Argentina that specializes in molecular testing and genetic diagnosis to provide personalized treatment for patients with cancer and rare diseases. The Argentinean company offers comprehensive testing programs and use artificial intelligence and predictive platforms to generate high-quality genomic information and develop deep scientific and bioinformatics analysis. Biomakers has a department of premium international logistics that guarantees the collection and transfer of biological samples to their laboratories with the best traceability and times at the regional level. The company also has strategic partnership agreements with world-leading drug companies for cancer and rare diseases. The company was founded by Nicolás Kirchuk and Rubén Salanova, and Nicolás Kirchuk has been the CEO since incorporation.

Biomakers Molecular Pathology & Research is a company based in Buenos Aires, Argentina that specializes in molecular testing and genetic diagnosis to provide personalized treatment for patients with cancer and rare diseases. The Argentinean company offers comprehensive testing programs and use artificial intelligence and predictive platforms to generate high-quality genomic information and develop deep scientific and bioinformatics analysis. Biomakers has a department of premium international logistics that guarantees the collection and transfer of biological samples to their laboratories with the best traceability and times at the regional level. The company also has strategic partnership agreements with world-leading drug companies for cancer and rare diseases. The company was founded by Nicolás Kirchuk and Rubén Salanova, and Nicolás Kirchuk has been the CEO since incorporation.

Biomakers Molecular Pathology & Research is a company based in Buenos Aires, Argentina that specializes in molecular testing and genetic diagnosis to provide personalized treatment for patients with cancer and rare diseases. The Argentinean company offers comprehensive testing programs and use artificial intelligence and predictive platforms to generate high-quality genomic information and develop deep scientific and bioinformatics analysis. Biomakers has a department of premium international logistics that guarantees the collection and transfer of biological samples to their laboratories with the best traceability and times at the regional level. The company also has strategic partnership agreements with world-leading drug companies for cancer and rare diseases. The company was founded by Nicolás Kirchuk and Rubén Salanova, and Nicolás Kirchuk has been the CEO since incorporation.